Yoo, B., Kim, A., Moon, H. S., So, M.-K., Jeong, T.-D., Lee, K. E., Moon, B.-I., & Huh, J. (2023). Evaluation of Group Genetic Counseling Sessions via a Metaverse-based Application. Annals of Laboratory Medicine, 44(1), 82–91. https://doi.org/10.3343/alm.2024.44.1.82

Terry, M. B., & Colditz, G. A. (2023). Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science. Cold Spring Harbor Perspectives in Medicine, 13(9), a041317. https://doi.org/10.1101/cshperspect.a041317

Tarchi, S. M., Pernia Marin, M., Hossain, Md. M., & Salvatore, M. (2023). Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis. Journal of Translational Medicine, 21(1). https://doi.org/10.1186/s12967-023-04457-0

Kalinsky, K., Accordino, M. K., Chiuzan, C., Mundi, P. S., Sakach, E., Sathe, C., Ahn, H., Trivedi, M. S., Novik, Y., Tiersten, A., Raptis, G., Baer, L. N., Oh, S. Y., Zelnak, A. B., Wisinski, K. B., Andreopoulou, E., Gradishar, W. J., Stringer-Reasor, E., Reid, S. A., … Hershman, D. L. (2023). Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of Clinical Oncology, 41(24), 4004–4013. https://doi.org/10.1200/jco.22.02392

Lichtiger, L., Jezioro, J., Rivera, J., McDonald, J. D., Terry, M. B., Sahay, D., & Miller, R. L. (2023). Prenatal airborne polycyclic aromatic hydrocarbon exposure, altered regulation of peroxisome proliferator-activated receptor gamma (Ppar)γ, and links with mammary cancer. Environmental Research, 231, 116213. https://doi.org/10.1016/j.envres.2023.116213

Koch, P. A., Paul, R., Contento, I. R., Gray, H. L., Marín-Chollom, A. M., Santiago-Torres, M., Shen, H., Jones, S. M. W., Hershman, D. L., & Greenlee, H. (2023). Mi Vida Saludable: Content Validity and Reliability of The Preferences and Self-Efficacy of Diet and Physical Activity Behaviors Questionnaire for Latina Women (PSEDPALW) for Cancer Survivors. Nutrients, 15(16), 3563. https://doi.org/10.3390/nu15163563

Morra, A., Schreurs, M. A. C., Andrulis, I. L., Anton‐Culver, H., Augustinsson, A., Beckmann, M. W., Behrens, S., Bojesen, S. E., Bolla, M. K., Brauch, H., Broeks, A., Buys, S. S., Camp, N. J., Castelao, J. E., Cessna, M. H., Chang‐Claude, J., Chung, W. K., Colonna, S. V., … Hooning, M. J. (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival. Cancer Medicine, 12(15), 16142–16162. Portico. https://doi.org/10.1002/cam4.6272

Trepanier, C., Huang, A., Liu, M., & Ha, R. (2023). Emerging uses of artificial intelligence in breast and axillary ultrasound. Clinical Imaging, 100, 64–68. https://doi.org/10.1016/j.clinimag.2023.05.007

Ding, Y. C., Song, H., Adamson, A. W., Schmolze, D., Hu, D., Huntsman, S., Steele, L., Patrick, C. S., Tao, S., Hernandez, N., Adams, C. D., Fejerman, L., Gardner, K., Nápoles, A. M., Pérez-Stable, E. J., Weitzel, J. N., Bengtsson, H., Huang, F. W., Neuhausen, S. L., & Ziv, E. (2023). Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. Cancer Research, 83(15), 2600–2613. https://doi.org/10.1158/0008-5472.can-22-2510

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Phakathi, B., Dix-Peek, T., Van Den Berg, E., Dickens, C., Nietz, S., Cubasch, H., Joffe, M., Neugut, A. I., Jacobson, J. S., Ruff, P., & Duarte, R. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment, 200(3), 337–346. https://doi.org/10.1007/s10549-023-06969-1

Xu, C., Lu, P., Pfob, A., Pusic, A. L., Hamill, J. B., & Sidey-Gibbons, C. (2023). Physical well-being recovery trajectories by reconstruction modality in women undergoing mastectomy and breast reconstruction: Significant predictors and health-related quality of life outcomes. PLOS ONE, 18(7), e0289182. https://doi.org/10.1371/journal.pone.0289182

Odai-Afotey, A., Lederman, R. I., Ko, N. Y., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Hershman, D. L., Crew, K. D., Keating, N. L., & Freedman, R. A. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment, 200(1), 127–137. https://doi.org/10.1007/s10549-023-06960-w

Acheampong, T., Rodríguez, C. B., O’Neill, S. C., Agovino, M., Argov, E. J. L., & Tehranifar, P. (2023). Scientific uncertainty and perceived mammography benefits in women screened for breast cancer. Cancer Causes & Control, 34(7), 611–619. https://doi.org/10.1007/s10552-023-01697-9

Hershman, D. L., Chen, B. E., Sathe, C., Parulekar, W. R., Lemieux, J., Ligibel, J. A., Gelmon, K. A., Whelan, T. J., & Goodwin, P. J. (2023). Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment, 200(1), 93–102. https://doi.org/10.1007/s10549-023-06922-2

Kinslow, C. J., Yu, J. B., DeStephano, D. M., Kachnic, L. A., Cheng, S. K., Neugut, A. I., & Horowitz, D. P. (2023). Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ. JAMA Surgery, 158(7), 769. https://doi.org/10.1001/jamasurg.2023.0262

Michel, A., Ro, V., McGuinness, J. E., Mutasa, S., Terry, M. B., Tehranifar, P., May, B., Ha, R., & Crew, K. D. (2023). Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors. Breast Cancer Research and Treatment, 200(2), 237–245. https://doi.org/10.1007/s10549-023-06966-4

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5

Sun, X., Zhang, Q., Kadier, K., Hu, P., Liu, X., Liu, J., Yan, Y., Sun, C., Yau, V., Lowe, S., Meng, M., Liu, Z., & Zhou, M. (2023). Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1059303

Matar-Ujvary, R., Haglich, K., Flanagan, M. R., Fuzesi, S., Sevilimedu, V., Nelson, J. A., & Gemignani, M. L. (2023). The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q. Annals of Surgical Oncology, 30(9), 5341–5349. https://doi.org/10.1245/s10434-023-13592-3

Siddique, M., Liu, M., Duong, P., Jambawalikar, S., & Ha, R. (2023). Deep Learning Approaches with Digital Mammography for Evaluating Breast Cancer Risk, a Narrative Review. Tomography, 9(3), 1110–1119. https://doi.org/10.3390/tomography9030091

Asadourian, P. A., Chen, Y., Jung, W., Wang, M. L., Koerner, A., Qin, N., de Freitas, D., Chinta, M., Andy, C., Rohde, C. H., & Otterburn, D. M. (2023). Return of the Flap; The Empire State Mandate. Annals of Plastic Surgery, 90(6S), S598–S606. https://doi.org/10.1097/sap.0000000000003490

O’Mahony, D. G., Ramus, S. J., Southey, M. C., Meagher, N. S., Hadjisavvas, A., John, E. M., Hamann, U., Imyanitov, E. N., Andrulis, I. L., Sharma, P., Daly, M. B., Hake, C. R., Weitzel, J. N., Jakubowska, A., Godwin, A. K., Arason, A., Bane, A., Simard, J., … Soucy, P. (2023). Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. British Journal of Cancer, 128(12), 2283–2294. https://doi.org/10.1038/s41416-023-02263-5

Sayed, S., Koka, H., Abubakar, M., Gardner, K., Salgado, R., Moloo, Z., Caban-Ureña, A. B., Rosen, D., Castro, P., Saleh, M., Shaikh, A. J., Shah, J., Figueroa, J., Makokha, F., Ha, H. K., Wang, Z., Magangane, P., Naidoo, R., Ngundo, V., … Govender, D. (2023). Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. Breast Cancer Research and Treatment, 199(2), 401–413. https://doi.org/10.1007/s10549-023-06921-3

Moran, G. W., Steinman, J. B., Tillotson, C. V., Carpenter, C. P., Hays, T., Ham, J. N., & Li, B. (2023). Virilization of a 46,XX Fetus Following Aromatase Inhibitor Treatment of Breast Cancer. Pediatrics, 151(6). https://doi.org/10.1542/peds.2022-060568

Brett, J. O., Dubash, T. D., Johnson, G. N., Niemierko, A., Mariotti, V., Kim, L. S. L., Xi, J., Pandey, A., Dunne, S., Nasrazadani, A., Lloyd, M. R., Kambadakone, A., Spring, L. M., Micalizzi, D. S., Onozato, M. L., Che, D., Nayar, U., Brufsky, A., Kalinsky, K., … Wander, S. A. (2023). A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00532

Dix-Peek, T., Phakathi, B. P., van den Berg, E. J., Dickens, C., Augustine, T. N., Cubasch, H., Neugut, A. I., Jacobson, J. S., Joffe, M., Ruff, P., & Duarte, R. A. B. (2023). Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Research and Treatment, 199(1), 1–12. https://doi.org/10.1007/s10549-023-06886-3

Hwong, A. R., Vittinghoff, E., Thomas, M., Hermida, R., Walkup, J., Crystal, S., Olfson, M., & Mangurian, C. (2023). Breast Cancer Screening Rates Among Medicaid Beneficiaries With Schizophrenia. Psychiatric Services, 74(5), 497–504. https://doi.org/10.1176/appi.ps.20220163

Lawrence, W. R., McDonald, J. A., Williams, F., Shiels, M. S., Freedman, N. D., Lin, Z., & Magnani, J. W. (2023). Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status. Cancer Prevention Research, 16(5), 259–267. https://doi.org/10.1158/1940-6207.capr-22-0472

Haslam, D. E., John, E. M., Knight, J. A., Li, Z., Buys, S. S., Andrulis, I. L., Daly, M. B., Genkinger, J. M., Terry, M. B., & Zhang, F. F. (2023). Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention, 32(5), 678–686. https://doi.org/10.1158/1055-9965.epi-22-1198

Serrano, D., Gandini, S., Thomas, P., Crew, K. D., Kumar, N. B., Vornik, L. A., Lee, J. J., Veronesi, P., Viale, G., Guerrieri-Gonzaga, A., Lazzeroni, M., Johansson, H., D’Amico, M., Guasone, F., Spinaci, S., Bertelsen, B.-E., Mellgren, G., Bedrosian, I., Weber, D., … Bonanni, B. (2023). Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor–Positive Breast Cancer. JAMA Oncology, 9(5), 664. https://doi.org/10.1001/jamaoncol.2023.0089

Gleckler, L., Roy, N., Bernstein, M., Balija, T. M., LaPlaca, C., Nevid, D. R., Lee, J. H., Port, E., & Bernik, S. F. (2023). Impact of Preoperative Extramammary Findings in Patients with Newly Diagnosed Breast Cancer. Journal of the American College of Surgeons, 236(5), 1047–1053. https://doi.org/10.1097/xcs.0000000000000605

El-Sadoni, M., Shboul, S. A., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., Ababneh, N. A., Alotaibi, M. R., Azab, B., & Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. Cancer Chemotherapy and Pharmacology, 91(4), 345–360. https://doi.org/10.1007/s00280-023-04523-w

Sivakumar, S., Jin, D. X., Rathod, R., Ross, J., Cantley, L. C., Scaltriti, M., Chen, J. W., Hutchinson, K. E., Wilson, T. R., Sokol, E. S., & Vasan, N. (2023). Genetic Heterogeneity and Tissue-specific Patterns of Tumors with MultiplePIK3CAMutations. Clinical Cancer Research, 29(6), 1125–1136. https://doi.org/10.1158/1078-0432.ccr-22-2270

Kumthekar, P. U., Avram, M. J., Lassman, A. B., Lin, N. U., Lee, E., Grimm, S. A., Schwartz, M., Bell Burdett, K. L., Lukas, R. V., Dixit, K., Perron, I., Zhang, H., Gradishar, W. J., Pentsova, E. I., Jeyapalan, S., Groves, M. D., Melisko, M., & Raizer, J. J. (2022). A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro-Oncology, 25(3), 557–565. https://doi.org/10.1093/neuonc/noac195

Sompuram, S. R., Vani, K., Ryan, L., Johnson, C., Szabolcs, M., Peruyero, L., Balaton, A., Pierrot, S., Joseph, L., Pilichowska, M., Naber, S., Goldsmith, J., Green, S., & Bogen, S. A. (2023). Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance. American Journal of Clinical Pathology, 159(3), 274–282. https://doi.org/10.1093/ajcp/aqac163

Mavaddat, N., Ficorella, L., Carver, T., Lee, A., Cunningham, A. P., Lush, M., Dennis, J., Tischkowitz, M., Downes, K., Hu, D., Hahnen, E., Schmutzler, R. K., Stockley, T. L., Downs, G. S., Zhang, T., Chiarelli, A. M., Bojesen, S. E., Liu, C., Chung, W. K., … Easton, D. F. (2023). Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer Epidemiology, Biomarkers & Prevention, 32(3), 422–427. https://doi.org/10.1158/1055-9965.epi-22-0756

Beauchemin, M. P., DeStephano, D., Raghunathan, R., Harden, E., Accordino, M., Hillyer, G. C., Kahn, J. M., May, B. L., Mei, B., Rosenblat, T., Law, C., Elkin, E. B., Kukafka, R., Wright, J. D., & Hershman, D. L. (2023). Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting. JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00172

Mapanga, W., Norris, S. A., Craig, A., Ayeni, O. A., Chen, W. C., Jacobson, J. S., Neugut, A. I., Ruff, P., Cubasch, H., O’Neil, D. S., Buccimazza, I., Čačala, S., Stopforth, L. W., Farrow, H. A., Nietz, S., Phakathi, B., Chirwa, T., McCormack, V. A., & Joffe, M. (2023). Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLOS ONE, 18(2), e0281916. https://doi.org/10.1371/journal.pone.0281916

Goldberg, M., McDonald, J. A., Houghton, L. C., Andrulis, I. L., Knight, J. A., Bradbury, A. R., Schwartz, L. A., Buys, S. S., Frost, C. J., Daly, M. B., John, E. M., Keegan, T. H. M., Chung, W. K., Wei, Y., & Terry, M. B. (2022). Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk. International Journal of Epidemiology, 52(1), 272–283. https://doi.org/10.1093/ije/dyac108

Zeleke, T. Z., Pan, Q., Chiuzan, C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., Mukhopadhyay, P., Kelly, S., Wu, R., Fenn, K., Trivedi, M. S., Accordino, M., Crew, K. D., Hershman, D. L., Maurer, M., … Silva, J. (2022). Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature Cancer, 4(2), 257–275. https://doi.org/10.1038/s43018-022-00489-5

Levy, A. S., Murphy, A. I., Ishtihar, S., Peysakhovich, A., Taback, B., Grant, R. T., Ascherman, J. A., Feldman, S., & Rohde, C. H. (2022). Lymphatic Microsurgical Preventive Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up. Plastic & Reconstructive Surgery, 151(2), 413–420. https://doi.org/10.1097/prs.0000000000009857

Ayeni, O. A., Chiwambutsa, S., Chen, W. C., Kapungu, N., Kanji, C., Thelingwani, R., Murugan, N., Mathiba, R., Phakathi, B., Nietz, S., Ramiah, D., O’Neil, D. S., Jacobson, J. S., Ruff, P., Cubasch, H., Chirwa, T., Joffe, M., Masimirembwa, C., & Neugut, A. I. (2022). The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Research and Treatment, 197(3), 647–659. https://doi.org/10.1007/s10549-022-06835-6

Tshiaba, P. T., Ratman, D. K., Sun, J. M., Tunstall, T. S., Levy, B., Shah, P. S., Weitzel, J. N., Rabinowitz, M., Kumar, A., & Im, K. M. (2023). Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00447

Meernik, C., Jorgensen, K., Wu, C.-F., Murphy, C. C., Baker, V. L., Brady, P. C., Nitecki, R., Nichols, H. B., & Rauh-Hain, J. A. (2023). Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Research and Treatment, 198(1), 149–158. https://doi.org/10.1007/s10549-022-06857-0

Shah, Y. B., Kjelstrom, S., Martinez, D., Leitenberger, A., Manasseh, D., Bollmann‐Jenkins, M., Partridge, A., Kaklamani, V., Chlebowski, R., Larson, S., & Weiss, M. (2022). Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients. Cancer Medicine, 12(3), 3577–3588. Portico. https://doi.org/10.1002/cam4.5184

Zhang, Y., Sun, C., Yau, V., Chen, S., Yang, Q., Chen, W., Lowe, S., Bentley, R., & Ouyang, Z. (2023). Clinical Features and Prognosis of Uncommon Metastatic Breast Cancer: A Retrospective Analysis of 82 Cases. Technology in Cancer Research & Treatment, 22. https://doi.org/10.1177/15330338231184990

Zhang, J., McGuinness, J. E., He, X., Jones, T., Silverman, T., Guzman, A., May, B. L., Kukafka, R., & Crew, K. D. (2023). Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women. American Journal of Preventive Medicine, 64(1), 51–60. https://doi.org/10.1016/j.amepre.2022.08.004

Lee Argov, E. J., Rodriguez, C. B., Agovino, M., Wei, Y., Shelton, R. C., Kukafka, R., Schmitt, K. M., Desperito, E., Terry, M. B., & Tehranifar, P. (2022). Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort. Breast Cancer Research, 24(1). https://doi.org/10.1186/s13058-022-01584-2

Cogan, J. C., Raghunathan, R. R., Beauchemin, M. P., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022). New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer. JNCI: Journal of the National Cancer Institute, 114(12), 1698–1705. https://doi.org/10.1093/jnci/djac170